Your browser doesn't support javascript.
loading
Conditional survival does not improve over time in metastatic castration-resistant prostate cancer patients undergoing docetaxel.
Modonutti, Daniele; Majdalany, Sami E; Butaney, Mohit; Davis, Matthew J; Corsi, Nicholas; Sood, Akshay; Trinh, Quoc-Dien; Cole, Alexander P; Rogers, Craig G; Novara, Giacomo; Abdollah, Firas.
Afiliación
  • Modonutti D; Department of Urology, Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation (VCORE), Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Majdalany SE; Department of Surgery, Oncology and Gastroenterology-Urology, University Hospital of Padova, Padova, Italy.
  • Butaney M; Department of Urology, Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation (VCORE), Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Davis MJ; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA.
  • Corsi N; Department of Urology, Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation (VCORE), Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Sood A; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA.
  • Trinh QD; Department of Urology, Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation (VCORE), Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Cole AP; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA.
  • Rogers CG; Department of Medicine, School of Medicine, Wayne State University, Detroit, Michigan, USA.
  • Novara G; Department of Urology, Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation (VCORE), Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Abdollah F; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA.
Prostate ; 83(13): 1238-1246, 2023 09.
Article en En | MEDLINE | ID: mdl-37290911
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Prostate Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Prostate Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos